经导管主动脉生物瓣膜患者的再次心脏手术
本研究回顾性分析了2011至2020年间在本机构接受经导管主动脉瓣置换术(TAVR)后需再次手术的48例患者,其中32例来自本机构1719例TAVR患者(2%),16例来自其他机构。主要再次手术为TAVR瓣膜取出联合外科主动脉瓣置换术(77%),院内死亡率为15%,观察值与预期值死亡比值为1.8。作者认为再次手术的必要性或不利的重复TAVR解剖在首次TAVR时即可预测。
要点
- TAVR术后再次手术率为2%,中位间隔2.3年。
- 77%的再次手术为TAVR瓣膜取出联合外科主动脉瓣置换术。
- 49%的非主动脉瓣病变在TAVR时已存在。
核心结论
- 尽管非计划主动脉修复随时间减少,TAVR术后再次手术的临床影响仍然重大。
- 再次手术的必要性或不利的重复TAVR解剖在首次TAVR时似乎可预测,植入者在候选选择时应考虑「终身管理」策略。
研究设计与样本
- 回顾性综述了2011年至2020年间在本机构接受TAVR的1719例患者中32例(2%)需再次手术,以及16例在其他机构接受TAVR后在本机构再次手术的患者,共48例。
- 从TAVR到再次手术的中位间隔为2.3年。
主要发现
- 主要再次手术包括37例(77%)TAVR瓣膜取出联合外科主动脉瓣置换术,8例(17%)二尖瓣修复/置换,2例(4%)冠状动脉旁路移植术,1例(2%)三尖瓣置换。
- 49%的非主动脉瓣心脏病变在TAVR时已存在。
- 18例(49%)TAVR瓣膜取出患者根据首次TAVR影像被判定为解剖上不适合重复TAVR。
- 在TAVR瓣膜取出术中,6例(13%)原生TAVR患者发生不同程度的主动脉创伤;需要非计划主动脉修复的患者窦管交界直径小于不需要修复的患者。
- 既往外科主动脉瓣置换术的14例患者或最近连续20例患者中无需非计划主动脉修复。
临床怎么用
- 作者认为,再次手术的必要性或不利的重复TAVR解剖在首次TAVR时似乎可预测,植入者在候选选择时应考虑「终身管理」策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the rapid adoption of transcatheter aortic valve replacement (TAVR), the frequency and clinical outcomes of reoperation after TAVR are not well-described. METHODS: Between 2011 and 2020, 1719 patients underwent a TAVR at our institution. Among these, 32 patients (2%) required a reoperation. Additionally, 16 patients who received a TAVR at another institution received a reoperation at our institution. We retrospectively reviewed these 48 patients. The median interval from TAVR to reoperation was 2.3 years. RESULTS: Primary reoperations included 37 TAVR valve explants (TAVR-explant; 77%) with surgical aortic valve replacement (SAVR), 8 mitral repairs/replacements (17%), 2 coronary artery bypass grafting procedures (4%), and 1 tricuspid valve replacement (2%). Forty-nine percent of nonaortic valve cardiac lesions were present at the time of TAVR. Furthermore, 18 TAVR-explant patients (49%) were deemed anatomically unsuitable for repeat TAVR based on the index TAVR imaging. During TAVR-explant, 6 patients (13%) with native TAVR sustained various degrees of aortic trauma. Patients with unplanned aortic repair demonstrated a smaller sinotubular junction diameter than those without unplanned repair. In contrast, no unplanned aortic repair was needed in the 14 patients with previous SAVR or the latest 20 consecutive patients. The overall in-hospital mortality was 15%, with an observed-to-expected morality ratio of 1.8. CONCLUSIONS: The clinical impact of post-TAVR reoperation remains substantial despite the lower frequency of unplanned aortic repair over time. The necessity of reoperations or unfavorable repeat TAVR anatomy appears predictable at the time of the index TAVR, and implanters must be mindful of "lifetime management" strategy during candidate selection.
引用
- Fukuhara S, Nguyen CTN, Yang B, et al. Cardiac Reoperations in Patients With Transcatheter Aortic Bioprosthesis. Ann Thorac Surg. 2022. PMID: 36179856. doi:10.1016/j.athoracsur.2022.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。